Frailty Index is Associated with Adverse Outcomes after Aortic Valve Replacement in Elderly Patients

Journal of Korean Medical Science 2019³â 34±Ç 31È£ p.205 ~ p.205

¼ÕºÀ¿¬(Sohn Bong-Yeon) - Seoul National University Hospital Department of Thoracic and Cardiovascular Surgery
ÃÖÀç¿õ(Choi Jae-Woong) - Seoul National University Hospital Department of Thoracic and Cardiovascular Surgery
Ȳȣ¿µ(Hwang Ho-Young) - Seoul National University Hospital Department of Thoracic and Cardiovascular Surgery
Àå¸íÁø(Jang Myoung-Jin) - Seoul National University Hospital Medical Research Collaborating Center
±è°æȯ(Kim Kyung-Hwan) - Seoul National University Hospital Department of Thoracic and Cardiovascular Surgery
±è±âºÀ(Kim Ki-Bong) - Seoul National University Hospital Department of Thoracic and Cardiovascular Surgery

Abstract

Background: This study was conducted to evaluate the prognostic value of the frailty index based on routine laboratory data (FI-L) in elderly patients who underwent surgical aortic valve replacement (SAVR).

Methods: A total of 154 elderly patients (¡Ã 75 years) (78.7 ¡¾ 3.6 years; men:women = 78:76) who underwent aortic valve replacement with stented bioprosthesis between 2001 and 2018 were enrolled. The FI-L was calculated as the proportion of abnormal results out of 32 items based on laboratory tests, pulse rate and blood pressure. The primary outcome was all-cause mortality. Secondary outcomes included operative mortality and aortic valve-related events (AVREs) during follow-up. The predictive values of FI-L for the early and late outcomes were evaluated using logistic regression and Cox proportional hazards models, respectively. The median follow-up duration was 40 months (interquartile, 15?74).

Results: The operative mortality rate was 3.9% (n = 6). Late death occurred in 29 patients. The overall survival (OS) rates at 5, 10, and 15 years were 83.3%, 59.0%, and 41.6%, respectively. The AVREs occurred in 28 patients and the freedom rates from AVREs at 5, 10, and 15 years were 79.4%, 72.7%, and 52.9%, respectively. Multivariable analyses demonstrated that FI-L was a significant factor for OS (hazard ratio, 1.075; 95% confidence interval, 1.040?1.111). A minimal P value approach showed that a FI-L of 25% was the best cutoff value to predict OS after SAVR.

Conclusion: The FI-L is significantly associated with early and long-term outcomes after SAVR in elderly patients. Frailty rather than a patient's age should be considered in the decision-making process for SAVR in elderly patients.

Å°¿öµå

Frailty, Elderly, Aortic Stenosis, Aortic Valve Replacement
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
FI-L was significantly associated with early and long-term mortality after SAVR in elderly patients
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå